Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
RAD011
DRUG
2 trials
Sponsors
Radius Pharmaceuticals, Inc.
Conditions
Prader-Willi Syndrome
Phase 2
A Study to Assess RAD011 (Cannabidiol Oral Solution) for the Treatment of Participants With Prader-Willi Syndrome
Terminated
NCT05098509
Radius Pharmaceuticals, Inc.
Prader-Willi Syndrome
Start: 2022-04-13
End: 2022-10-31
Updated: 2023-10-19
Phase 3
A Phase 3 Extension Study of RAD011 (Cannabidiol Oral Solution) in Patients With Prader-Willi Syndrome
Withdrawn
NCT05387798
Radius Pharmaceuticals, Inc.
Prader-Willi Syndrome
Start: 2023-01-31
End: 2025-08-31
Updated: 2022-10-06